EC restores number of star campaigners as COVID-19 cases wane

The Election Commission has said that now the maximum limit on the number of star campaigners for recognised national and state political parties "shall be 40 and for other than recognised political party it shall be 20."

PTI

February 20, 2022 / 18:28 IST

Representative Image (PTI)

Citing the decline in COVID-19 cases, the Election Commission Sunday restored the number of star campaigners a party can field for campaigning in the ongoing polls in five states.

Now, recognised national and state parties can field a maximum of 40 star campaigners. Other parties which are registered but not recognised can now have 20 star campaigners.

The Commission had in October 2020 reduced the number of star campaigners for recognised national and state parties from 40 to 30, as large gatherings were witnessed during campaigning in Bihar assembly elections and bypolls in several states amid the coronavirus pandemic.

For unrecognised registered political parties, the maximum number of star campaigners was brought down to 15 from 20. … the numbers of both active and new COVID-19 cases are receding and the restrictions put in place both by the central government and state governments to check the spread of pandemic are being lifted gradually…The Election Commission after due deliberation has decided to restore the maximum limit on the number of star campaigners…," it said in a letter to political parties.

The letter said now the maximum limit on the number of star campaigners for recognised national and state political parties "shall be 40 and for other than recognised political party it shall be 20."

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show